Drug Enforcement D-1094-2023

Subpotent Drug; sub-potent Bromfenac levels, below the 90.0-110.0% specification range.

Status

Terminated

Classification

Class III

Report Date

August 30, 2023

Termination Date

January 22, 2024

Product Information

Product description
Moxifloxacin - Bromfenac Sterile Ophthalmic Solution 0.5% / 0.075%, 5mL bottle, Imprimis NJOF, LLC. 1705 Route 46 West, Unit 6B, Ledgewood, NJ 07852 (844)-446-6979, NDC: 71384-311-05.
Product quantity
2,683 bottles
Reason for recall
Subpotent Drug; sub-potent Bromfenac levels, below the 90.0-110.0% specification range.
Recall initiation reason
Initial firm notification
N/A
Distribution pattern
Nationwide in the US

Location & Firm

Recalling firm
Imprimis NJOF, LLC
Address
1705 Route 46 Ste 6B, N/A

United States
Voluntary / Mandated
Voluntary: Firm initiated
Status date

Codes & Dates

Recall number
D-1094-2023
Event ID
92848
Recall initiation date
August 10, 2023
Center classification date
August 21, 2023
Code info
Lot #s: 22DEC047 exp 9/16/23, 23FEB057 exp 11/24/23.
More code info